J7193 Factor ix non-recombinant
Also known as: Factor IX, prothrombin complex, Christmas factor
Injection of Factor IX non-recombinant (plasma-derived), a vitamin K-dependent coagulation factor for hemophilia B treatment.
In Plain Language
clotting factor replacement; hemophilia B treatment
Clinical Context
Used for treatment and prophylaxis of bleeding in hemophilia B (Factor IX deficiency) patients.
RVU Information
CPT J7193 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7193?
CPT J7193 (Factor ix non-recombinant) is a J Codes (Drugs) code. Injection of Factor IX non-recombinant (plasma-derived), a vitamin K-dependent coagulation factor for hemophilia B treatment.
How is J7193 administered?
CPT J7193 is administered by a healthcare provider, typically via injection or infusion. Used for treatment and prophylaxis of bleeding in hemophilia B (Factor IX deficiency) patients. It is used by Hematology, Hemophilia Specialty Clinic, Surgery.
When is CPT J7193 used?
Used for treatment and prophylaxis of bleeding in hemophilia B (Factor IX deficiency) patients.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.